Massive DNA bank launched to unlock secrets of rare eye diseases

NCT ID NCT00378742

Completed Knowledge-focused Sponsor: National Eye Institute (NEI) Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study created a national DNA and blood repository for inherited eye diseases like retinitis pigmentosa. Over 6,600 participants provided blood samples and eye exam data to help researchers identify genetic causes. The stored samples are available to scientists without personal identifiers, aiming to accelerate research into future gene-based treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this repository could help researchers identify genetic causes of inherited eye diseases and speed up development of future gene-based therapies.
What could go wrong: This is a sample-collection study, not a treatment trial. It does not test any therapy, so direct patient benefits are not expected from participation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INHERITED OPHTHALMIC DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

macular degeneration retinitis pigmentosa

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INHERITED OPHTHALMIC DISEASES RETINITIS PIGMENTOSA

Contacts and locations

Locations

National Institutes of Health Clinical Center

Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.